www.fdanews.com/articles/151949-takeda-announces-mutual-termination-of-amylin-takeda-worldwide-agreement-to-co-develop-and-commercialize-compounds-for-obesity

Takeda Announces Mutual Termination of Amylin/Takeda Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity

December 26, 2012

Takeda Pharmaceutical Company announced that it has mutually terminated its worldwide agreement with Amylin Pharmaceuticals, originally signed in October 2009, to co-develop and commercialize compounds for obesity.
Yahoo! Finance